Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockGet instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
Constronics Infra Ltd (CONSTRONIC) is currently trading at 54.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Constronics Infra Limited, formerly Invicta Meditek Limited, transitioned from a pharma company to focus on construction and infrastructure. It was established in 1992 and shifted its main objective in 2018. The company engages in various construction projects and trades materials like Blue Metals and M-Sand. This marked a significant pivot from its previous pharmaceutical operations to become a player in infrastructure. Constronics Infra's transition highlights a strategic shift driven by new management objectives, signaling an adaptive and possibly opportunistic approach to market needs. Originally launched a unique BP knee replacement system in 2007, demonstrating prior involvement in medical technology before its strategic pivot.
Over the past 52 weeks, Constronics Infra Ltd has traded between a low of ₹40.70 and a high of ₹91.48. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Constronics Infra Ltd has a market capitalization of approximately 61.87. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Constronics Infra Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 10.24 and operates in the Trading sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 61.87 Cr, Constronics Infra Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Constronics Infra Ltd operates in the Trading sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Constronics Infra Ltd is 10.24. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
5
Neutral
6
Bullish
3
Bearish
18
Neutral
6
Bullish
22
Bearish
13
Neutral
0
Bullish
19
Encumbrance Disclosure
On Mar 5, 2026 promoter Vishnuvardhan disclosed creation of pledge encumbrances over his full promoter holding (13,31,558 shares, ~10.39% of equity) in favour of SBICAP Trustee/State Bank of India to secure ~Rs.19 crore term loan of a wholly‑owned subsidiary; encumbrances created Feb/Mar 2026.
Encumbrance Disclosure
Promoter Vishnuvardhan of Constronics Infra Ltd has pledged 13,31,558 shares (100% of promoter stake; ~10.5% of total share capital) to SBICAP Trustee/State Bank of India as security for a Rs.19 crore term loan to its subsidiary; events dated Feb 17 & Mar 2, 2026; disclosure filed Mar 05, 2026.
Promoter Encumbrance
Promoter Vishnuvardhan disclosed creation of a pledge on promoter shares of Constronics Infra on March 2, 2026: ~1,319,748 shares (~10.5% of total) (promoter holding 1,331,558) pledged in favour of SBICAP Trustee/SBI to secure ~₹19 crore term loan availed by his wholly‑owned subsidiary.
Encumbrance Disclosure
Promoter Vishnuvardhan pledged 1,319,748 shares (≈10.53% of total; 100% of his 1,331,558 holding) of Constronics Infra on Mar 02, 2026 as security for a Rs.19 crore term loan taken by its wholly‑owned subsidiary from State Bank of India (reported Mar 05, 2026).
Insider Trading Disclosure
Constronics Infra Ltd disclosed under SEBI (PIT) Reg 7(2) dated 05-Mar-2026 that promoter Vishnuvardhan pledged 13,190,748 equity shares (pledge executed on March 2, 2026).
Insider Trading Disclosure
Constronics Infra promoter Vishnuvardhan disclosed a pledge of equity shares (holding 13,190,748 shares, ~10.53%); pledge executed on 02-Mar-2026 and disclosed on 05-Mar-2026 under Reg 7(2) SEBI (PIT).
Constronics Infra Limited, formerly Invicta Meditek Limited, transitioned from a pharma company to focus on construction and infrastructure. It was established in 1992 and shifted its main objective in 2018.
The company engages in various construction projects and trades materials like Blue Metals and M-Sand. This marked a significant pivot from its previous pharmaceutical operations to become a player in infrastructure.
Constronics Infra's transition highlights a strategic shift driven by new management objectives, signaling an adaptive and possibly opportunistic approach to market needs.
Originally launched a unique BP knee replacement system in 2007, demonstrating prior involvement in medical technology before its strategic pivot.
Trading
Trading - Medium / Small
62 Cr
Low Risk
10.2
35.9
0.1
1.8
91.48
40.70
Sales CAGR
Profit CAGR
ROE
ROCE
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
9.65 | 63 Cr | -8.82 | 1.61 | 0.00 | 7.02 | 4.14 | 2.02 | |
0.97 | 62 Cr | 9.24 | 0.87 | 0.00 | 6.54 | 8.73 | 4.50 | |
47.00 | 62 Cr | 10.24 | 1.76 | 0.00 | — | — | 0.00 | |
60.24 | 61 Cr | 26.54 | 1.54 | 0.00 | 4.47 | 7.95 | 3.38 | |
77.09 | 60 Cr | 6.04 | 0.99 | 1.95 | 17.58 | 25.56 | 10.58 | |
0.56 | 60 Cr | -11.20 | 0.44 | 0.00 | 8.86 | 9.10 | -3.37 | |
91.00 | 60 Cr | 1300.00 | 0.27 | 2.20 | 3.77 | 2.94 | 0.02 |
